Breaking News Instant updates and real-time market news.

DY

Dycom

$30.37 /

-12.32 (-28.86%)

08:27
02/27/20
02/27
08:27
02/27/20
08:27

Dycom price target lowered to $38 from $47 at DA Davidson

DA Davidson analyst Brent Thielman lowered the firm's price target on Dycom to $38 from $47 and keeps a Neutral rating on the shares. The analyst cites the company's Q4 earnings miss and below-consensus Q1 guidance, adding that the outlook commentary suggests that growth will be delayed until at least the second half of FY20. Thielman adds that while Dycom's bookings and cash flows improved in Q4, those trends do not look to be sustainable in the near term.

DY Dycom
$30.37 /

-12.32 (-28.86%)

12/10/19 B. Riley FBR
Dycom selloff after note withdrawal unwarranted, says B. Riley FBR
09/17/19 Wells Fargo
Dycom price target raised to $61 from $52 at Wells Fargo
05/22/19 Craig-Hallum
Dycom price target raised to $65 from $51 at Craig-Hallum
05/22/19 Wells Fargo
Dycom price target raised to $63 from $50 at Wells Fargo

TODAY'S FREE FLY STORIES

Downgrade
Hennes & Mauritz downgraded to Underperform from Neutral at Exane BNP Paribas » 06:54
04/01/20
04/01
06:54
04/01/20
06:54
HNNMY

Hennes & Mauritz

/

+

Exane BNP Paribas analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Verint price target lowered to $52 from $64 at RBC Capital » 06:54
04/01/20
04/01
06:54
04/01/20
06:54
VRNT

Verint

$42.73 /

-0.04 (-0.09%)

RBC Capital analyst Dan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Mallinckrodt, Novoteris receive Health Canada clearance for Thiolanox trial » 06:54
04/01/20
04/01
06:54
04/01/20
06:54
MNK

Mallinckrodt

$1.97 /

-0.27 (-12.05%)

Mallinckrodt and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
Profound Medical initiated with an Outperform at Cowen » 06:54
04/01/20
04/01
06:54
04/01/20
06:54
PROF

Profound Medical

$9.60 /

-0.11 (-1.13%)

Cowen analyst Joshua…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
LyondellBasell downgraded to Neutral from Outperform at Exane BNP Paribas » 06:53
04/01/20
04/01
06:53
04/01/20
06:53
LYB

LyondellBasell

$49.51 /

-0.11 (-0.22%)

Exane BNP Paribas analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Organigram price target lowered to C$5.80 from C$9.00 at Cantor Fitzgerald » 06:52
04/01/20
04/01
06:52
04/01/20
06:52
OGI

Organigram

$1.98 /

-0.035 (-1.74%)

Cantor Fitzgerald analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Covestro downgraded to Neutral from Outperform at Exane BNP Paribas » 06:52
04/01/20
04/01
06:52
04/01/20
06:52
COVTY

Covestro

$0.00 /

+ (+0.00%)

Exane BNP Paribas analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Gannett sees operating performance 'adversely affected' by COVID-19 » 06:52
04/01/20
04/01
06:52
04/01/20
06:52
GCI

Gannett

$1.49 /

-0.46 (-23.65%)

The company said,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Kingfisher downgraded to Neutral from Outperform at Exane BNP Paribas » 06:51
04/01/20
04/01
06:51
04/01/20
06:51
KGFHY

Kingfisher

$0.00 /

+ (+0.00%)

Exane BNP Paribas analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Gannett suspends quarterly dividend » 06:51
04/01/20
04/01
06:51
04/01/20
06:51
GCI

Gannett

$1.49 /

-0.46 (-23.65%)

The company said,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Aphria price target lowered to C$9.30 from C$11.50 at Cantor Fitzgerald » 06:51
04/01/20
04/01
06:51
04/01/20
06:51
APHA

Aphria

$3.05 /

-0.025 (-0.81%)

Cantor Fitzgerald analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
U.S. Bancorp upgraded to Outperform with $57 price target at Oppenheimer » 06:51
04/01/20
04/01
06:51
04/01/20
06:51
USB

U.S. Bancorp

/

+

Oppenheimer analyst Chris…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Asos downgraded to Neutral from Outperform at Exane BNP Paribas » 06:50
04/01/20
04/01
06:50
04/01/20
06:50
ASOMY

Asos

$0.00 /

+ (+0.00%)

Exane BNP Paribas analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
O-I Glass to hold 2020 Annual Meeting of Share Owners as virtual event » 06:49
04/01/20
04/01
06:49
04/01/20
06:49
OI

O-I Glass

$7.09 /

+0.43 (+6.46%)

O-I Glass announced a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Corteva upgraded to Outperform from Neutral at Exane BNP Paribas » 06:48
04/01/20
04/01
06:48
04/01/20
06:48
CTVA

Corteva

$23.49 /

-0.63 (-2.61%)

Exane BNP Paribas analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Express says furloughing most store associates, freezing hiring » 06:47
04/01/20
04/01
06:47
04/01/20
06:47
EXPR

Express

$1.49 /

-0.15 (-9.15%)

Express provided an…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Axalta Coating upgraded to Outperform from Neutral at Exane BNP Paribas » 06:46
04/01/20
04/01
06:46
04/01/20
06:46
AXTA

Axalta Coating

$17.24 /

-0.825 (-4.57%)

Exane BNP Paribas analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

General news
FX Action: USD-CAD and CAD-JPY are the biggest movers » 06:45
04/01/20
04/01
06:45
04/01/20
06:45

FX Action: USD-CAD and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

General news
Week of 3/27 MBA Mortgage Applications to be released at 07:00  06:45
04/01/20
04/01
06:45
04/01/20
06:45
 
Recommendations
Bristol-Myers Squibb CVR price target raised to $6.17 from $4.52 at Mizuho » 06:43
04/01/20
04/01
06:43
04/01/20
06:43
BMY-R

Bristol-Myers Squibb CVR

$0.00 /

+ (+0.00%)

, BMY

Bristol-Myers

$55.76 /

+1.41 (+2.59%)

Mizuho analyst Salim Syed…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Dixons Carphone upgraded to Outperform from Neutral at Exane BNP Paribas » 06:43
04/01/20
04/01
06:43
04/01/20
06:43
DSITF

Dixons Carphone

$0.00 /

+ (+0.00%)

Exane BNP Paribas analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
C.H. Robinson upgraded to Buy from Neutral at UBS » 06:41
04/01/20
04/01
06:41
04/01/20
06:41
CHRW

C.H. Robinson

$66.19 /

+1.09 (+1.67%)

UBS analyst Thomas…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Zogenix price target lowered to $64 from $71 at Mizuho » 06:40
04/01/20
04/01
06:40
04/01/20
06:40
ZGNX

Zogenix

$24.72 /

-0.92 (-3.59%)

Mizuho analyst Difei Yang…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Turquoise Hill downgraded to Neutral from Outperformer at CIBC » 06:40
04/01/20
04/01
06:40
04/01/20
06:40
TRQ

Turquoise Hill

$0.39 /

+0.0202 (+5.42%)

CIBC analyst Oscar…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Hudbay Minerals downgraded to Neutral from Outperformer at CIBC » 06:39
04/01/20
04/01
06:39
04/01/20
06:39
HBM

Hudbay Minerals

$1.90 /

+0.11 (+6.15%)

CIBC analyst Oscar…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.